Novartis Eye-Care Unit Alcon Eyes Japan For Next Big Drug, Device Market
This article was originally published in PharmAsia News
Alcon, a subsidiary of Swiss-based Novartis, has turned its focus to Japan where it plans to make that market for eye-care products as big as those it already has in Europe and the U.S.
You may also be interested in...
France has announced a number of emergency measures to protect drug supplies threatened by the spread of the coronavirus.
Major generics companies have donated hydroxychloroquine sulfate doses for research and treatment of coronavirus. Companies are also donating hand sanitizer and personal protective equipment and are preparing to ramp up manufacturing and production.
Inovio forges ahead into Phase I trials with DNA-based vaccine candidate, but can it prove skeptics wrong?